McAfee John L, Warren Christine B, Prayson Richard A
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Department of Dermatology, Cleveland Clinic, Cleveland, OH, USA.
Ann Diagn Pathol. 2017 Aug;29:41-45. doi: 10.1016/j.anndiagpath.2017.02.010. Epub 2017 Apr 28.
Ultrastructural evaluation of skin biopsies has been utilized for diagnosis of mitochondrial disease. This study investigates how frequently skin biopsies reveal mitochondrial abnormalities, correlates skin and muscle biopsy findings, and describes clinical diagnoses rendered following the evaluation. A retrospective review of surgical pathology reports from 1990 to 2015 identified skin biopsies examined by electron microscopy for suspected metabolic disease. A total of 630 biopsies were included from 615 patients. Of these patients, 178 also underwent a muscle biopsy. Of the 630 skin biopsies, 75 (12%) showed ultrastructural abnormalities and 34 (5%) specifically showed mitochondrial abnormalities including increased size (n=27), reduced or abnormal cristae (n=23), dense matrices (n=20), and increased number (n=8). Additional findings included lysosomal abnormalities (n=13), lipid accumulation (n=2) or glycogen accumulation (n=1). Of the 34 patients with mitochondrial abnormalities on skin biopsy, 20 also had muscle biopsies performed and nine showed abnormalities suggestive of a mitochondrial disorder including absent cytochrome oxidase staining (n=2), increased subsarcolemmal NADH, SDH, or cytochrome oxidase staining (n=1), or ultrastructural findings including large mitochondrial size (n=5), abnormal mitochondrial structure (n=5), and increased mitochondrial number (n=4). The most common presenting symptoms were intellectual disability (n=13), seizures (n=12), encephalopathy (n=9), and gastrointestinal disturbances (n=9). At last known follow-up, 12 patients had a definitive diagnosis of a mitochondrial disorder. One patient each had Complex I deficiency, Complex III deficiency, Charcot-Marie-Tooth disease, pyruvate dehydrogenase deficiency, and Phelan-McDermid syndrome. Our results suggest that skin biopsy sometimes yields diagnostic clues suggestive of a mitochondrial cytopathy in cases with a negative muscle biopsy.
皮肤活检的超微结构评估已被用于线粒体疾病的诊断。本研究调查了皮肤活检显示线粒体异常的频率,关联了皮肤和肌肉活检结果,并描述了评估后的临床诊断。对1990年至2015年手术病理报告进行回顾性分析,确定了因怀疑代谢性疾病而接受电子显微镜检查的皮肤活检病例。共纳入615例患者的630份活检标本。其中178例患者还接受了肌肉活检。在630份皮肤活检标本中,75份(12%)显示超微结构异常,34份(5%)特别显示线粒体异常,包括大小增加(n = 27)、嵴减少或异常(n = 23)、基质致密(n = 20)和数量增加(n = 8)。其他发现包括溶酶体异常(n = 13)、脂质蓄积(n = 2)或糖原蓄积(n = 1)。在34例皮肤活检显示线粒体异常的患者中,20例也进行了肌肉活检,9例显示提示线粒体疾病的异常,包括细胞色素氧化酶染色缺失(n = 2)、肌膜下NADH、SDH或细胞色素氧化酶染色增加(n = 1),或超微结构发现,包括线粒体大(n = 5)、线粒体结构异常(n = 5)和线粒体数量增加(n = 4)。最常见的首发症状是智力残疾(n = 13)、癫痫发作(n = 12)、脑病(n = 9)和胃肠道紊乱(n = 9)。在最后一次已知随访时,12例患者确诊为线粒体疾病。分别有1例患者患有复合体I缺乏症、复合体III缺乏症、夏科-马里-图斯病、丙酮酸脱氢酶缺乏症和费伦-麦克德米德综合征。我们的结果表明,在肌肉活检为阴性的病例中,皮肤活检有时会产生提示线粒体细胞病的诊断线索。